Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The mitochondrial inner membrane (IMM) is a highly specialized lipid bilayer that serves as the functional heart of cellular energy metabolism, housing the electron transport chain (ETC) and ATP synthase (Alberts et al., Molecular Biology of the Cell, 2002). The mitochondrial membrane potential (MMP) is the electrical component of the electrochemical proton gradient established by the ETC, typically maintained at a high negative value (-150 to -180 mV) relative to the cytosol (Zorova et al., Analytical Biochemistry, 2018). This potential is indispensable for driving the synthesis of ATP, facilitating the import of essential proteins, and regulating mitochondrial ion homeostasis and signaling (Perry et al., Methods in Cell Biology, 2011). In pathological states, the IMM and its potential are often compromised; cancer cells frequently exhibit hyperpolarization to support metabolic reprogramming and resist cell death, whereas depolarization is a common feature of mitochondrial dysfunction in neurodegenerative and cardiovascular diseases (Chen, Annual Review of Cell Biology, 1988). Therapeutic interventions targeting this system include uncoupling agents that dissipate the gradient to increase metabolic flux and mitotropic compounds designed to selectively deliver antioxidants or other payloads to the mitochondrial matrix (Smith et al., Annals of the New York Academy of Sciences, 2015).
Pharmacological agents interact with the mitochondrial inner membrane and its potential through several mechanisms: protonophores (uncouplers) transport protons across the membrane to dissipate the electrochemical gradient; lipophilic cations utilize the negative potential to accumulate within the matrix; and electron transport chain inhibitors prevent the generation of the potential by blocking redox reactions.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial inner membrane and membrane potential (IMM/MMP).